How to tackle antimalarial resistance?
Graphical Abstract In the context of drug resistance, malaria is no exception. Even the latest artemisinins have started to lose their full efficacy in patients. Didier Leroy tells us about the strategies adopted by Medicines for Malaria Venture to reduce this terrible culprit.
Saved in:
| Main Author: | Didier Leroy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2016-12-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201607295 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
One Health approaches to tackling antimicrobial resistance
by: M.E.J. Woolhouse
Published: (2024-01-01) -
A just war on bugs? Ethical differences between antimalarial resistance and antibacterial resistance
by: Phaik Yeong Cheah, et al.
Published: (2025-08-01) -
A reaction-diffusion system modeling the spread of resistance to an antimalarial drug
by: Nicolas Bacaër, et al.
Published: (2005-02-01) -
Leveraging Digital Innovations to Combat Antimalarial Resistance in South and East Africa
by: Dr Stephanie Van Wyk, et al.
Published: (2025-03-01) -
Isolation and validation of antimalarial compounds from Phyllanthus emblica leaves for new antimalarial drug development
by: Selvam Naveenkumar, et al.
Published: (2025-05-01)